cypermethrin has been researched along with Kidney Diseases in 2 studies
cypermethrin : A carboxylic ester resulting from the formal condensation between 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylic acid and the alcoholic hydroxy group of hydroxy(3-phenoxyphenyl)acetonitrile.
zeta-cypermethrin : A diastereoisomeric mixture comprising the isomeric pair (1R)-cis-(alphaS)- and (1S)-trans-(alphaR)-cypermethrin together with the isomeric pair (1S)-cis-(alphaS)- and (1S)-trans-(alphaS)-cypermethrin where the ratio between the isomeric pairs lies in the range 45:55 to 55:45.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cypermethrin (CYP) is an important type II pyrethroid pesticide widely used to protect crops against pests and insect infestations." | 1.56 | Nephrotoxicity of cypermethrin in rats. Histopathological aspects. ( Alalwani, AD, 2020) |
| "Cypermethrin (CM) is an important type II pyrethroid pesticide used extensively in pest control and is reported to cause hepatic and renal toxicity." | 1.36 | Aqueous extract of Trigonella foenum graecum (fenugreek) prevents cypermethrin-induced hepatotoxicity and nephrotoxicity. ( Devasena, T; Sushma, N, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alalwani, AD | 1 |
| Sushma, N | 1 |
| Devasena, T | 1 |
2 other studies available for cypermethrin and Kidney Diseases
| Article | Year |
|---|---|
Nephrotoxicity of cypermethrin in rats. Histopathological aspects.
Topics: Animals; Dose-Response Relationship, Drug; Insecticides; Kidney Diseases; Kidney Tubules, Distal; Ki | 2020 |
Aqueous extract of Trigonella foenum graecum (fenugreek) prevents cypermethrin-induced hepatotoxicity and nephrotoxicity.
Topics: Animals; Antioxidants; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease M | 2010 |